Myeloma UK initiates MUK nine clinical trial for myeloma

Non-profit organisation Myeloma UK has initiated an MUK nine clinical trial that will use genetic techniques to stratify therapy for high-risk myeloma patients in the country.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news